Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple Sclerosis
Clinical trial NCT04880577 · WITHDRAWN
Trial details
- NCT number
- NCT04880577
- Sponsor
- Massachusetts General Hospital
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-15
- Primary completion
- 2024-02-14
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.